Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

Trial Setbacks May Delay Progress in Gonorrhea Prevention

The incidence of gonorrhea continues to rise across Europe, while recent vaccine trials show limited efficacy, raising concerns about prevention strategies.

Lilly's Obesity Pill Records Modest Second Week as Battle With Novo Intensifies

Eli Lilly's newly launched weight-loss pill had a modest second week, analysts said on Friday, as competition with ⁠Danish rival Novo Nordisk heats up in the oral obesity...

HT: A Proactive Approach to Menopause Management

Proactive use of hormone therapy may help improve the quality of life and health of perimenopausal and menopausal women.

Continued Insulin Pump Use in the Hospital Improves Outcomes

Allowing patients to keep using their personal diabetes technology during hospitalization improves glycemic control and reduces length of stay.

Use of GLP-1s in Type 1 Diabetes Not Linked to Increased DKA

In single-center study, GLP-1 use in people with type 1 diabetes was associated with lower hospitalization rates.

UnitedHealth Flags Challenges in Medicare Obesity Drug Pilot

UnitedHealth said on Tuesday there are "challenges" around the Medicare pilot program to cover obesity drugs, ⁠adding uncertainty over whether health insurers would sign up...

Todays Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?

A cohort study compares the distribution and progression risk among individuals classified as having high-risk smoldering multiple myeloma by the AQUILA trial inclusion criteria vs 2/20/20 risk model.

Todays Updates

Which Risk Model Better Identifies High-Risk Smoldering MM?

A cohort study compares the distribution and progression risk among individuals classified as having high-risk smoldering multiple myeloma by the AQUILA trial inclusion criteria vs 2/20/20 risk model.

Latest News

The incidence of gonorrhea continues to rise across Europe, while recent vaccine trials show limited efficacy, raising concerns about prevention strategies.

Eli Lilly's newly launched weight-loss pill had a modest second week, analysts said on Friday, as competition with ⁠Danish rival Novo Nordisk heats up in the oral obesity...

Proactive use of hormone therapy may help improve the quality of life and health of perimenopausal and menopausal women.

Allowing patients to keep using their personal diabetes technology during hospitalization improves glycemic control and reduces length of stay.

In single-center study, GLP-1 use in people with type 1 diabetes was associated with lower hospitalization rates.

UnitedHealth said on Tuesday there are "challenges" around the Medicare pilot program to cover obesity drugs, ⁠adding uncertainty over whether health insurers would sign up...

News All Time

GLP-1 Boom Nudges Cannabis Dispensaries to Rethink Offerings

The surging popularity of GLP-1 weight-loss drugs is quietly reshaping the $40 billion U.S. cannabis market, experts and industry executives said, as retailers ⁠adjust...

Evidence Grows for Weight Loss Reducing Cancer Risk

With studies showing that the increased cancer risk linked to obesity can be reduced with weight loss, experts call for greater awareness.

The Science of piRNA and Predicting Death With a Blood Test

A new study analyzed piRNA — first discovered in 2006 — as a strong predictor of short-term survival in older patients. It could one day be a simple blood test.

Air Pollution’s Toll on Bone Health

Research links air pollution and heavy metals to accelerated bone loss and higher fracture rates, driven by systemic inflammation, oxidative stress, and endocrine disruption.

Combining Insulin Pump, CGM Into One Device Appears Feasible

Early proof-of-concept study showed that a patch pump with integrated glucose sensing at the site of insulin delivery can function in people with type 1 diabetes.

PCOS Linked to Later Menopause and Fewer Symptoms

A population-based study reveals that women with PCOS are less likely to reach late perimenopause or postmenopause by their mid-40s than their peers and experience fewer menopausal symptoms.

Thyroid Dysfunction Tied to NAFLD in Children With Obesity

Elevated levels of thyroid-stimulating hormone may signal the presence of non-alcoholic fatty liver disease in children and adolescents with obesity, according to a meta-analysis of 10 studies.

Why Constipation Remains Underrecognized in Pregnancy

Hormonal changes, reduced motility, and mechanical factors drive constipation during pregnancy, which requires targeted assessment and safe management.

Lilly CEO Sees Weight-loss Drugs Reaching About Half Of Potential Users At Peak

Weight-loss drugs may eventually reach only about 50% of the overweight and obese people who could benefit from them due to complexities of healthcare systems ⁠and financial...

Restrictive Food Disorder Prevalence Overestimated

Avoidant/restrictive food intake disorder was inconsistently identified in patients with GI disorders, likely leading to overestimation of its prevalence.

M1 Variant Lowers APOL1 Kidney Disease Risk

Although APOL1 variants are linked to kidney disease risk, the presence of the M1 genetic variant appears to reduce that risk.

‘Secret Shopper’ Study Finds Risks in Compounded GLP-1s

Study on compounded GLP-1s uncovers use of additives and questionable sterility practices, revealing legally ‘murky’ area.

Weekend Catch-Up Sleep May Harm Glucose Control

A large NHANES analysis suggests that 7 hours of sleep may represent a metabolic sweet spot, whereas too little, too much, or excessive weekend catch-up sleep may worsen insulin resistance.

Microbiome May Predict Fiber-Induced Bloating

Few patients with bloating experience symptoms from fermentable fibers, with predictors including a higher baseline symptom burden and distinct gut microbiome patterns.

Updated AACE Algorithms Guide Type 2 Diabetes Management

New graphics and text address prediabetes, T2D, and management of cardiovascular risk factors.

Ontario Action Plan Aims to Increase Access to Primary Care

The provincial government is entering a physician services agreement with the goal of attracting and retaining more family doctors.

Recommended News For You

Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.

Don't Call It Cancer; Clues to 'Exceptional' Responses; More Predictions for 2025

According to research, the mineralization of the bone matrix controls the growth of tumor cells.

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.

Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.

Recommended Articles For You

The Silent Danger of Hematoma: How to Identify and Treat This Potentially Serious Condition 

Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era 

Understanding Odontogenic Keratocyst: Symptoms, Causes, and Treatments from Dental Experts 

Interplay of Brown Hair, Follicular Biology, and Hair Growth Inhibitors in Melanoma Pathogenesis 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.

2.

Guideline on management of early-stage non-small cell lung cancer released

3.

Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.

4.

Medical debt in collections persists after cancer diagnosis

5.

Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

1.

Malignant Prolactinoma: Prolactin Surge with Minimal Growth Masks Widespread Metastases

2.

Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment

3.

Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options 

4.

Hemophilia: Pathophysiology, Genetics, and Treatment Advances

5.

Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

2.

Role of Nimotuzumab in Management of Nasopharyngeal Cancer

3.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot